May 21, 2019
FDA approves Fragmin- an anticoagulant for children The FDA today approved Fragmin for the treatment of blood clots. Pfizer’s candidate Fragmin which was earlier approved for the treatment of only adults suffering from a fatal disease called VTE, which can include deep vein thrombosis (blood clot in the d...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper